Portal
Order

MI Cancer Seek® is now available for clinical ordering. Learn more.

Home / Research / Publications / CXCR4 overexpression: an indicator of poor survival and predictor of response to immunotherapy in patients with metastatic colorectal cancer

Publications

Back

CXCR4 overexpression: an indicator of poor survival and predictor of response to immunotherapy in patients with metastatic colorectal cancer

– Caris Life Sciences

Poster

Key Finding:

Colorectal cancer patients with high tumoral CXCR4 expression had improved survival when treated with pembrolizumab. 

Download Publication

Discover
More

  • Adult Granulosa Cell Tumor with Rare Pulmonary Presentation

    – Caris Life Sciences

    Manuscript

    Abstract Adult granulosa cell tumor (GCT) is an uncommon sex cord-stromal neoplasm of the ovary. It typically demonstrates locoregional spread, and disease outside of the… […]

  • Characterization of plasma cell-free DNA variants as of tumor- or clonal hematopoiesis-origin in 16,812 advanced cancer patients

    – Caris Life Sciences

    Manuscript

    Abstract  Purpose: Plasma-based liquid biopsy tests can detect tumor-specific genetic alterations and offer many advantages that complement tissue-based Comprehensive Genomic Profiling (CGP). However, age-related clonal hematopoiesis… […]
Learn More

Ready to Get Started on the Journey?

Name(Required)